Holding back the sea: the role for maintenance chemotherapy in metastatic breast cancer

Breast Cancer Res Treat. 2010 Jul;122(1):177-9. doi: 10.1007/s10549-010-0925-9. Epub 2010 May 11.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / therapeutic use*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Cross-Over Studies
  • Disease Progression
  • Disease-Free Survival
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Liposomes
  • Multicenter Studies as Topic
  • Neoplasm Metastasis
  • Paclitaxel / therapeutic use
  • Paresthesia / chemically induced
  • Polyethylene Glycols / adverse effects
  • Polyethylene Glycols / therapeutic use*
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Research Design
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Liposomes
  • liposomal doxorubicin
  • Polyethylene Glycols
  • Doxorubicin
  • Paclitaxel